HPLC hodnocení vybraných léčiv VI.

Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical Chemistry and Drug Control Candidate: Barbora Kadaňková Consultant: RNDr. Milan Mokrý, CSc. Title of Thesis: HPLC hodnocení vybraných léčiv VI. This thesis focuses on assay optimization for simultaneous q...

Full description

Bibliographic Details
Main Author: Kadaňková, Barbora
Other Authors: Mokrý, Milan
Format: Dissertation
Language:Czech
Published: 2012
Online Access:http://www.nusl.cz/ntk/nusl-308214
id ndltd-nusl.cz-oai-invenio.nusl.cz-308214
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-3082142017-06-28T04:16:16Z HPLC hodnocení vybraných léčiv VI. HPLC evaluation of select drugs VI. Kadaňková, Barbora Mokrý, Milan Kučera, Radim Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical Chemistry and Drug Control Candidate: Barbora Kadaňková Consultant: RNDr. Milan Mokrý, CSc. Title of Thesis: HPLC hodnocení vybraných léčiv VI. This thesis focuses on assay optimization for simultaneous quantitation of valsartan and hydrochlorothiazide in combined tablets. First, chromatographic conditions were tested and optimized settings were then used for tablet content determination. Good chromatographic separation was achieved using an ET Nucleosil (125x4.6 mm, 120-5, C8) column and a mobile phase consisting of acetonitrile : ammonium acetate (0.001 mol/l) in the ratio of 25:75 (v/v) with addition of sodium hexanesulfonate (0.002 mol/l). The solution was acidified with acetic acid to pH 3.50 and then adjusted to pH 7.00 using disodium hydrogen phosphate. The mobile phase was pumped at a flow rate of 1.0 ml/min and UV detector was set at 254 nm. Methylparaben was used as internal standard. Individual compounds eluted in the following order: 1) hydrochlorothiazide, 2) valsartan and 3) methylparaben. The linearity range for valsartan and hydrochlorothiazide quantitation was 0.08-0.24 mg/ml and 0.012-0.036 mg/ml, respectively. 2012 info:eu-repo/semantics/masterThesis http://www.nusl.cz/ntk/nusl-308214 cze info:eu-repo/semantics/restrictedAccess
collection NDLTD
language Czech
format Dissertation
sources NDLTD
description Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical Chemistry and Drug Control Candidate: Barbora Kadaňková Consultant: RNDr. Milan Mokrý, CSc. Title of Thesis: HPLC hodnocení vybraných léčiv VI. This thesis focuses on assay optimization for simultaneous quantitation of valsartan and hydrochlorothiazide in combined tablets. First, chromatographic conditions were tested and optimized settings were then used for tablet content determination. Good chromatographic separation was achieved using an ET Nucleosil (125x4.6 mm, 120-5, C8) column and a mobile phase consisting of acetonitrile : ammonium acetate (0.001 mol/l) in the ratio of 25:75 (v/v) with addition of sodium hexanesulfonate (0.002 mol/l). The solution was acidified with acetic acid to pH 3.50 and then adjusted to pH 7.00 using disodium hydrogen phosphate. The mobile phase was pumped at a flow rate of 1.0 ml/min and UV detector was set at 254 nm. Methylparaben was used as internal standard. Individual compounds eluted in the following order: 1) hydrochlorothiazide, 2) valsartan and 3) methylparaben. The linearity range for valsartan and hydrochlorothiazide quantitation was 0.08-0.24 mg/ml and 0.012-0.036 mg/ml, respectively.
author2 Mokrý, Milan
author_facet Mokrý, Milan
Kadaňková, Barbora
author Kadaňková, Barbora
spellingShingle Kadaňková, Barbora
HPLC hodnocení vybraných léčiv VI.
author_sort Kadaňková, Barbora
title HPLC hodnocení vybraných léčiv VI.
title_short HPLC hodnocení vybraných léčiv VI.
title_full HPLC hodnocení vybraných léčiv VI.
title_fullStr HPLC hodnocení vybraných léčiv VI.
title_full_unstemmed HPLC hodnocení vybraných léčiv VI.
title_sort hplc hodnocení vybraných léčiv vi.
publishDate 2012
url http://www.nusl.cz/ntk/nusl-308214
work_keys_str_mv AT kadankovabarbora hplchodnocenivybranychlecivvi
AT kadankovabarbora hplcevaluationofselectdrugsvi
_version_ 1718473507305684992